Concepedia

Haruhiko Yamada

HY

Statistics

Publications

2

Citations

378

H-Index

2

Active since

2000

Affiliations

Novartis (Switzerland)(Current)

Haruhiko Yamada is an author at Novartis (Switzerland) specializing in ophthalmology, retinal surgery, and susceptibility gene function.

Publications per year

2000–2007

2

Publications

2

Blockade of Vascular Endothelial Cell Growth Factor Receptor Signaling Is Sufficient to Completely Prevent Retinal Neovascularization

Hiroaki Ozaki, Man‐Seong Seo, Keiko Ozaki et al. · American Journal Of Pathology · 2000 · 345 citations · Full text

, , +11

Systematic screening of lysyl oxidase-like (LOXL) family genes demonstrates that LOXL2 is a susceptibility gene to intracranial aneurysms

Hiroyuki Akagawa, Akira Narita, Haruhiko Yamada et al. · Human Genetics · 2007 · 33 citations

, , +7

1–2 of 2